HRP20050359B1 - Novi postupak za industrijsku sintezu stroncij renalata i njegovih hidrata - Google Patents

Novi postupak za industrijsku sintezu stroncij renalata i njegovih hidrata

Info

Publication number
HRP20050359B1
HRP20050359B1 HRP20050359AA HRP20050359A HRP20050359B1 HR P20050359 B1 HRP20050359 B1 HR P20050359B1 HR P20050359A A HRP20050359A A HR P20050359AA HR P20050359 A HRP20050359 A HR P20050359A HR P20050359 B1 HRP20050359 B1 HR P20050359B1
Authority
HR
Croatia
Prior art keywords
hydrates
novel method
industrial synthesis
strontium ranelate
strontium
Prior art date
Application number
HRP20050359AA
Other languages
English (en)
Croatian (hr)
Inventor
Lucile Vaysse-Ludot
Jean-Piere Lecouve
Pascal Langlois
Original Assignee
Les Laboratoires Servier
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Les Laboratoires Servier filed Critical Les Laboratoires Servier
Publication of HRP20050359A2 publication Critical patent/HRP20050359A2/xx
Publication of HRP20050359B1 publication Critical patent/HRP20050359B1/hr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Inorganic Insulating Materials (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Plural Heterocyclic Compounds (AREA)
HRP20050359AA 2002-09-24 2003-09-22 Novi postupak za industrijsku sintezu stroncij renalata i njegovih hidrata HRP20050359B1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0211763A FR2844795B1 (fr) 2002-09-24 2002-09-24 Nouveau procede de synthese industriel du ranelate de strontium et de ses hydrates
PCT/FR2003/002777 WO2004029036A1 (fr) 2002-09-24 2003-09-22 Nouveau procede de synthese industriel du ranelate de strontium et de ses hydrates

Publications (2)

Publication Number Publication Date
HRP20050359A2 HRP20050359A2 (en) 2005-06-30
HRP20050359B1 true HRP20050359B1 (hr) 2014-09-26

Family

ID=29415189

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20050359AA HRP20050359B1 (hr) 2002-09-24 2003-09-22 Novi postupak za industrijsku sintezu stroncij renalata i njegovih hidrata

Country Status (37)

Country Link
US (1) US7214805B2 (enExample)
EP (1) EP1403266B1 (enExample)
JP (1) JP4136867B2 (enExample)
KR (1) KR100551501B1 (enExample)
CN (1) CN1212321C (enExample)
AP (1) AP1910A (enExample)
AR (1) AR041355A1 (enExample)
AU (2) AU2003282179A1 (enExample)
BR (1) BR0304213A (enExample)
CA (1) CA2442878C (enExample)
CR (1) CR7764A (enExample)
CY (1) CY1115162T1 (enExample)
DK (1) DK1403266T3 (enExample)
EA (1) EA007489B1 (enExample)
EC (1) ECSP055741A (enExample)
ES (1) ES2478620T3 (enExample)
FR (1) FR2844795B1 (enExample)
GE (1) GEP20074215B (enExample)
HR (1) HRP20050359B1 (enExample)
IL (1) IL167316A (enExample)
IS (1) IS7807A (enExample)
MA (1) MA26102A1 (enExample)
ME (1) ME00455B (enExample)
MX (1) MXPA03008643A (enExample)
MY (1) MY134921A (enExample)
NO (1) NO328638B1 (enExample)
NZ (1) NZ528402A (enExample)
OA (1) OA12934A (enExample)
PL (1) PL214400B1 (enExample)
PT (1) PT1403266E (enExample)
RS (2) RS53509B1 (enExample)
SG (1) SG110071A1 (enExample)
SI (1) SI1403266T1 (enExample)
TN (1) TNSN05087A1 (enExample)
UA (1) UA79156C2 (enExample)
WO (1) WO2004029036A1 (enExample)
ZA (1) ZA200307409B (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004098618A2 (en) * 2003-05-07 2004-11-18 Osteologix A/S Strontium combinations for prophylaxis/treatment of cartilage and/or bone conditions
ES2275218T3 (es) * 2003-05-07 2007-06-01 Osteologix A/S Sales de estroncio hidrosolubles para el tratamiento de afecciones de cartilagos y/o huesos.
PL1732575T3 (pl) 2004-02-26 2011-05-31 Osteologix As Związki zawierające stron do stosowania w zapobieganiu lub leczeniu stanów nekrotycznych kości
JP4954867B2 (ja) * 2004-05-06 2012-06-20 オステオロジックス エイ/エス 有機金属塩類を製造するための高収率で迅速な合成法
CA2571449C (en) 2004-06-25 2015-12-08 John Nikolaj Hvarre Christensen Compositions comprising strontium and vitamin d and uses thereof
FR2875807B1 (fr) * 2004-09-30 2006-11-17 Servier Lab Forme cristalline alpha du ranelate de strontium, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
CN100538672C (zh) * 2005-04-18 2009-09-09 索尼株式会社 控制设备和方法
CN100391955C (zh) * 2005-04-30 2008-06-04 河北医科大学 一种雷尼酸锶中间体的合成方法
CA2619720A1 (en) * 2005-08-19 2007-02-22 Glenmark Pharmaceuticals Limited Process for the preparation of strontium ranelate
US20070292535A1 (en) * 2006-06-19 2007-12-20 Tabbiner Philip S Strontium compositions and methods of treating arthritic and or osteoporitic conditions
US20070292529A1 (en) * 2006-06-19 2007-12-20 Tabbiner Philip S Strontium compositions and methods of treating osteoporotic conditions
FR2921367B1 (fr) * 2007-09-26 2009-10-30 Servier Lab Nouveau procede de synthese du ranelate de strontium et de ses hydrates
US20120123131A1 (en) * 2008-08-22 2012-05-17 Koilpillai Joseph Prabahar Process for the preparation of strontium ranelate
HU228820B1 (en) 2010-01-14 2013-05-28 Richter Gedeon Nyrt Process for the preparation of distrontium ranelate
WO2011110597A1 (de) 2010-03-11 2011-09-15 Azad Pharmaceutical Ingredients Ag Verfahren zur herstellung von strontiumranelat
WO2011124992A1 (en) * 2010-03-24 2011-10-13 Actavis Group Ptc Ehf Substantially pure strontium ranelate
US9301945B2 (en) 2011-07-21 2016-04-05 Emory University Methods for treating inflammatory conditions and states, and cancers by antagonizing NF-κB activation
CN102321068B (zh) * 2011-08-01 2013-01-23 山东铂源药业有限公司 一种雷奈酸锶的制备方法
WO2013175270A1 (en) * 2012-05-25 2013-11-28 Fleming Laboratories Limited Improved process for the preparation of strontium ranelate hydrates and new polymorphic form of monohydrate
ES2505716T3 (es) 2013-01-21 2015-09-04 Galenicum Health S.L. Composiciones farmacéuticas que comprenden una sal de ácido
CN103319454B (zh) * 2013-06-14 2014-06-18 广东众生药业股份有限公司 一种高纯度雷尼酸四乙酯及其中间体的制备方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0415850A1 (fr) * 1989-09-01 1991-03-06 Adir Et Compagnie Sels de métaux bivalents de l'acide N, N-di(carboxyméthyl)amino-2 cyano-3 carboxyméthyl-4 carboxy-5 thiophène,leur procédé de préparation et les compositions pharmaceutiques les renfermant
EP0813869A1 (fr) * 1996-06-17 1997-12-29 Adir Et Compagnie Utilisation de sels de strontium pour le traitement de l'arthrose

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2844797B1 (fr) * 2002-09-24 2004-10-22 Servier Lab Nouveau procede de synthese industriel des tetraesters de l'acide 5-[bis (carboxymethyl)]-3-carboxymethyl-4-cyano-2- thiophenecarboxylique, et application a la synthese des sels bivalents de l'acide ranelique et de leurs hydrates
FR2844796A1 (fr) * 2002-09-24 2004-03-26 Servier Lab Nouveau procede de synthese industrielle du diester methylique de l'acide 5-amino-3-carboxymethyl-4-cyano-2- thiophenecarboxylique, et application a la synthese des sels bivalents de l'acide ranelique et de leurs hydrates

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0415850A1 (fr) * 1989-09-01 1991-03-06 Adir Et Compagnie Sels de métaux bivalents de l'acide N, N-di(carboxyméthyl)amino-2 cyano-3 carboxyméthyl-4 carboxy-5 thiophène,leur procédé de préparation et les compositions pharmaceutiques les renfermant
EP0813869A1 (fr) * 1996-06-17 1997-12-29 Adir Et Compagnie Utilisation de sels de strontium pour le traitement de l'arthrose

Also Published As

Publication number Publication date
AU2003282179A1 (en) 2004-04-19
TNSN05087A1 (fr) 2007-05-14
DK1403266T3 (da) 2014-07-07
AU2003248281B2 (en) 2009-08-06
ZA200307409B (en) 2004-07-07
AP1910A (en) 2008-10-30
ME00455B (me) 2011-10-10
CA2442878C (fr) 2009-03-03
CN1212321C (zh) 2005-07-27
KR100551501B1 (ko) 2006-02-13
FR2844795A1 (fr) 2004-03-26
ECSP055741A (es) 2005-07-06
CR7764A (es) 2005-10-06
AU2003248281A1 (en) 2004-04-08
HRP20050359A2 (en) 2005-06-30
NO20034235D0 (no) 2003-09-23
EP1403266B1 (fr) 2014-04-09
JP4136867B2 (ja) 2008-08-20
KR20040026625A (ko) 2004-03-31
NO20034235L (no) 2004-03-25
OA12934A (en) 2006-10-13
BR0304213A (pt) 2004-08-31
CY1115162T1 (el) 2016-12-14
PL214400B1 (pl) 2013-07-31
PL362365A1 (en) 2004-04-05
FR2844795B1 (fr) 2004-10-22
PT1403266E (pt) 2014-05-06
IL167316A (en) 2008-08-07
US7214805B2 (en) 2007-05-08
AR041355A1 (es) 2005-05-11
EP1403266A1 (fr) 2004-03-31
NZ528402A (en) 2004-07-30
NO328638B1 (no) 2010-04-12
WO2004029036A1 (fr) 2004-04-08
RS53509B1 (sr) 2015-02-27
CA2442878A1 (fr) 2004-03-24
GEP20074215B (en) 2007-10-10
RS20050240A (sr) 2007-06-04
SG110071A1 (en) 2005-04-28
IS7807A (is) 2005-04-19
MA26102A1 (fr) 2004-04-01
ES2478620T3 (es) 2014-07-22
SI1403266T1 (sl) 2014-06-30
CN1496986A (zh) 2004-05-19
JP2004149516A (ja) 2004-05-27
EA007489B1 (ru) 2006-10-27
MXPA03008643A (es) 2005-04-19
MY134921A (en) 2008-01-31
HK1065791A1 (en) 2005-03-04
EA200300925A1 (ru) 2004-04-29
US20040063972A1 (en) 2004-04-01
UA79156C2 (en) 2007-05-25
AP2005003256A0 (en) 2005-03-31

Similar Documents

Publication Publication Date Title
HRP20050359B1 (hr) Novi postupak za industrijsku sintezu stroncij renalata i njegovih hidrata
DE602004030334D1 (de) Synthese von 5-substituierten 7-azaindolen und 7-azaindolinen
EA200401157A1 (ru) N-аминоацетилпирролидин-2-карбонитрилы и их применение в качестве ингибиторов ddp-iv
PL372926A1 (en) Piperidine-pyridazones and phthalazones as pde4 inhibitors
SE0000540D0 (sv) New compounds
MX339074B (es) Piperacinil y diacepanil benzamidas y benztioamidas.
SG151207A1 (en) New process for the synthesis of strontium ranelate and its hydrates
MXPA03009548A (es) Arilsulfonamidas como agentes antivirales.
EA200300927A1 (ru) Новый способ промышленного синтеза тетрасложных эфиров 5-[бис(карбоксиметил)амино]-3-карбоксиметил-4-циано-2-тиофенкарбоновой кислоты и применение для синтеза бивалентных солей ранелиновой кислоты и их гидратов
HRP20080057T3 (en) 9,10-alpha,alpha-oh-taxane analogs and methods for production thereof
DE60316984D1 (de) Benzoylsulfonamide als antitumor-mittel
MY131939A (en) New process for the industrial synthesis of the methyl diester of 5-amino-3-carboxymethyl-4-cyano-2-thiophenecarboxylic acid, and application to the synthesis of bivalent salts of ranelic acid and their hydrates
MXPA05010398A (es) Nuevo metodo para la sintesis del acido (2s)-indolin-2-carboxilico y aplicacion de mismo en la sintesis del perindopril.
HRP20050382A2 (en) Novel pyrimidine-4,6-dicarboxamides for the selective inhibition of collagenases
BRPI0416678A (pt) pirazolpirimidinas
AU2003269363A1 (en) Azo compounds
ATE287403T1 (de) 6-phenylbenzonaphthyidine
MXPA06003345A (es) Derivados de aminopiridina como inhibidores de la no-sintasa inducible.
GB0215392D0 (en) Chemical compounds
GB0103240D0 (en) Organic compounds
EA200600608A1 (ru) Производные имидазопиридина как ингибиторы индуцируемой no-синтазы
EA200500204A1 (ru) Новый способ синтеза (7-метокси-1-нафтил)ацетонитрила и его применение при синтезе агомелатина
MXPA04010500A (es) Imidazopiridinas nitrosadas.
MY139289A (en) Process for the synthesis of perindopril and pharmaceutically acceptable salts thereof
MXPA03012073A (es) Amidoderivados heterociclicos.

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
B1PR Patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20160707

Year of fee payment: 14

PBON Lapse due to non-payment of renewal fee

Effective date: 20170922